Portuguese PT English EN Spanish ES

Blog Details

  • Home
  • Immunobiologicals Case – Structuring an access strategy through Focus Group

[:pb]

One of the biggest sources of innovation in the pharmaceutical industry today is biological medicines. The high complexity that they have demands more specialization in all the processes of elaboration of this technology.

In this context, a pharmaceutical laboratory had the challenge of mapping the segment in Brazil in order to promote the incorporation of technology as accurately as possible. Find out how the Focus Group solution adopted by MAPES enabled a strategic result, with distinct and relevant points of view for all involved stakeholders.

To learn more about our solutions for incorporating healthcare technologies, download the MAPES e-book: HERE.

Leave Comment